Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Suspected Justin Sun address withdraws 3.2 million USDT from Spark again

Suspected Justin Sun address withdraws 3.2 million USDT from Spark again

ChaincatcherChaincatcher2026/05/01 02:17
Show original

According to ChainCatcher, on-chain analyst Ai Yi has monitored that a suspected address belonging to Justin Sun has once again withdrawn 3.2 million USDT from Spark, with a cumulative total of 96.62 million USD stablecoins withdrawn.

The financial management address 0x939…6A1D1 currently still holds 1.15 billion USD funds on Spark, including 1.02 billion USDS and 131 million USDC. Previously, after an alleged sale of 5.51 million USD in USDS Farming rewards, the new rewards have now accumulated to nearly 600 thousand USD.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The second wave of energy price increases is looming! European Central Bank’s Lane warns: eurozone inflation will be higher and more persistent

Philip Lane, Chief Economist of the European Central Bank, stated that a new round of high energy prices means inflation in the eurozone will remain elevated for longer than the ECB initially anticipated.

智通财经2026/09/22 07:56

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11